PathoCapital Leads $5M Investment in ReliefBand Technologies to Fuel Consumer Market Introduction of FDA Cleared Device for the Treatment of Nausea
ReliefBand Technologies, a leader in therapeutic technology has announced it has raised $5 million in venture capital funding in…